Trial Profile
Role of Fidaxomicin in a Patient Population With Problematic Clostridium Difficile Infection
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Dec 2023
Price :
$35
*
At a glance
- Drugs Fidaxomicin (Primary) ; Vancomycin
- Indications Clostridium difficile infections
- Focus Therapeutic Use
- 12 Oct 2016 Status changed from recruiting to discontinued.
- 29 Sep 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017.
- 29 Sep 2016 Planned primary completion date changed from 1 Feb 2016 to 1 Feb 2017.